Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.0%

12 terminated/withdrawn out of 172 trials

Success Rate

89.3%

+2.7% vs industry average

Late-Stage Pipeline

35%

61 trials in Phase 3/4

Results Transparency

12%

12 of 100 completed trials have results

Key Signals

13 recruiting12 with results6 terminated6 withdrawn

Enrollment Performance

Analytics

N/A

58(39.7%)

Phase 3

39(26.7%)

Phase 4

22(15.1%)

Phase 2

18(12.3%)

Phase 1

8(5.5%)

Early Phase 1

1(0.7%)

146Total

N/A(58)

Phase 3(39)

Phase 4(22)

Phase 2(18)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (172)

Showing 20 of 172 trials

NCT05394363Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Role: collaborator

NCT07822022Not ApplicableNot Yet Recruiting

Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP)

Role: collaborator

NCT02273375Phase 3Completed

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Role: collaborator

NCT07576335Phase 2Recruiting

Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy

Role: collaborator

NCT03057106Phase 2Active Not Recruiting

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Role: collaborator

NCT03573089Not ApplicableRecruiting

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

Role: collaborator

NCT06159660Recruiting

Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy

Role: collaborator

NCT03685045Not ApplicableRecruiting

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Role: collaborator

NCT07136584Not ApplicableRecruiting

SOS for Caregiver Wellbeing

Role: collaborator

NCT02446444Phase 3Active Not Recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Role: collaborator

NCT06262776Not ApplicableRecruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Role: collaborator

NCT06992141Early Phase 1Completed

A Strep Throat Controlled Human Infection Trial in Healthy Adults

Role: collaborator

NCT05402657Not ApplicableCompleted

The RAFT ECT Study

Role: collaborator

NCT07434180Phase 2Not Yet Recruiting

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Role: collaborator

NCT04478370Not ApplicableCompleted

Characterizing Humoral Immune Response to Mosquito Bites

Role: collaborator

NCT01320345Phase 3Active Not Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Role: collaborator

NCT00430989Phase 4Completed

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

Role: collaborator

NCT01424150Not ApplicableCompleted

REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study

Role: collaborator

NCT02632760Phase 4Completed

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

Role: collaborator

NCT04192435Phase 4Completed

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery

Role: collaborator